American Journal of Kidney Diseases
Volume 41 , Pages 3-10 , June 2003

Meeting the challenges of the new K/DOQI guidelines

  • Garabed Eknoyan, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Garabed Eknoyan, MD, Professor of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    • Baylor College of Medicine, Houston, TX, USA

  • Image Result

    Adjusted first-year patient death rates by treatment modality and year of incidence, 1988 to 1997. Reprinted with permission.3

    Adjusted first-year patient death rates by treatment modality and year of incidence, 1988 to 1997. Reprinted with permission.3

  • Image Result

    Diagram illustrating the relative points in time when problems related to CKD begin to develop. Many relevant health issues in patients with CKD, such as malnutrition, CVD, and anemia, begin to occur

    Diagram illustrating the relative points in time when problems related to CKD begin to develop. Many relevant health issues in patients with CKD, such as malnutrition, CVD, and anemia, begin to occur in the earliest stages of CKD. Failure to address these issues long before patients present for hemodialysis therapy may greatly increase the risk for adverse outcomes. Abbreviations: CRF, chronic renal failure; CRI, chronic renal insufficiency; PRF, progressive renal failure; RRT, renal replacement therapy; TX, transplant; HD, hemodialysis; PD, peritoneal dialysis; NKF-DOQI, National Kidney Foundation-Dialysis Outcomes Quality Initiative.

  • Image Result
    Prevalence of LVH by level of kidney function. LVH is already present in 30% of patients with mild renal insufficiency (creatinine clearance, 50 to 75 mL/min). To convert mL/min to mL/s multiply by 0.

    Prevalence of LVH by level of kidney function. LVH is already present in 30% of patients with mild renal insufficiency (creatinine clearance, 50 to 75 mL/min). To convert mL/min to mL/s multiply by 0.01667. Reprinted with permission.5

  • Image Result
    Stages in progression of CKD and therapeutic strategies. Reprinted with permission.4

    Stages in progression of CKD and therapeutic strategies. Reprinted with permission.4

  • Image Result
    Correlation of GFR with (A) creatinine clearance and (B) MDRD Study equation. Reprinted with permission.10

    Correlation of GFR with (A) creatinine clearance and (B) MDRD Study equation. Reprinted with permission.10

  • Image Result
    Serum creatinine levels versus GFRs in 171 patients with glomerular disease. Solid circles joined by continuous line represent the hypothetical relationship between GFR and serum creatinine level when

    Serum creatinine levels versus GFRs in 171 patients with glomerular disease. Solid circles joined by continuous line represent the hypothetical relationship between GFR and serum creatinine level when creatinine is excreted solely by glomerular filtration. The broken horizontal line represents the upper limit of normal for serum creatinine level in the laboratory that conducted the test (1.4 mg/dL [124 μmol/L]). To convert mg/dL to μmol/L, multiply by 88.4. Reprinted with permission.14

  • Image Result
    Prevalence of hypertension stratified according to GFR in the NHANES III population. Abbreviation: SBP, systolic blood pressure.4

    Prevalence of hypertension stratified according to GFR in the NHANES III population. Abbreviation: SBP, systolic blood pressure.4

  • Image Result
    Proportion of patients by number of abnormalities (Abn) by level of GFR in the NHANES III population.4

    Proportion of patients by number of abnormalities (Abn) by level of GFR in the NHANES III population.4

 Supported by an unrestricted educational grant from Watson Pharma, Inc.

PII: S0272-6386(03)00371-8

doi: 10.1016/S0272-6386(03)00371-8

American Journal of Kidney Diseases
Volume 41 , Pages 3-10 , June 2003